80
Participants
Start Date
October 31, 2010
Primary Completion Date
June 30, 2011
Study Completion Date
August 31, 2011
Carvedilol
"Oral, twice daily dosing using 3.125 mg tablets.~1 week titration (6.25 mg/day)prior to a 3 week flexible dosing option ranging from 6.25 mg/day to 15.625 mg/day followed by a 1 week taper (6.25 mg/day)."
Placebo
Non active comparator
Lake Charles Clinical Trials, Lake Charles
Artemis Institute for Clinical Research, San Diego
Northwest Clinical Research Center, Bellevue
Lead Sponsor
Columbia Northwest Pharmaceuticals
INDUSTRY